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INTRODUCTION
The  orbit  contains  variety  of  tissues  including  bone,  extra  ocular  muscles, 
peripheral  nerves,  cranial  nerves,  fibro  vascular  adipose  tissue  and  cartilage  and  a 
variety  of  systemic  disorders  may  manifest  in  the  orbit  of  which  orbital  tumors 
constitute the major category. Diseases of the orbit create some of the most complex and 
perplexing problems in ophthalmology The initial clinical evaluation of the patient with 
an orbital lesion is frequently inconclusive .After taking the patient’s history and then 
examining  the  patient  there  invariably  remains  enough  uncertainties  to  require 
consultation  with  other  specialists  and  referral  for  radiological  and  ultrasonographic 
studies . Very often, a desirable end result of the workup is the localization of the lesion 
to a particular area of the orbit, thereby facilitating the surgical exposure of the lesion 
and  permitting  its  excision.  Such  a  complex  subject  deserves  a  precise  table  of 
organization; unfortunately none exists. The small confines of the orbit and the anterior 
location of the eye ball  limit  direct observation or palpation of orbital  tumors.  Even 
knowledge  of  the  approximate  size,  location  and  consistency  of  the  lesion  is  not 
effective means of sorting out the various lesions of the orbit. Additional information 
regarding the direction degree and rate of progression of proptosis and other information 
does not facilitate the formulation of a workable classification.  Classifications of the 
orbital disease derived from the use of ultrasonography and computerized tomography 
have become very helpful;  however such data are usually not available at the initial 
evaluation. Perhaps the most commonly used classification is one based on the review of 
histopathologic material 1.  The reported incidence of orbital tumors varies widely from 
series to series depending on the material studied .One finds a considerable difference in 
the incidence of various lesions in series derived from biopsy material as compared with 
those that include clinical diagnosis without histopathological verification .Series from 
large  ophthalmic  departments  have  inherent  bias  depending  on  the  referral  patterns 
special interests of the ophthalmologist and other factors 2. This study intends to study 
the spectrum of orbital tumors in a tertiary eye care centre.
          
REVIEW OF 
LITERATURE
The reported incidence of orbital tumors varies from series to series depending primarily on the 
source of the material reviewed .Variation in frequency of different tumors in different series can have 
relationship to national ,regional and other socioeconomic factors. Biopsy proven series is recognized 
for the certainty and prognostic aspect. A clinical series represents a wider practical correlation and 
may include cases not likely to be biopsied.
Daniel Silva M.D published a study in 1968 on orbital tumors which included 300 patients, all 
of whom underwent surgery at least for biopsy .Pseudo tumors were the most common group followed 
by mucocoeles and orbital expansion of retinoblastoma. The unusually high incidence of 
retinoblastomas with orbital involvement was explained by the fact that the hospital was an oncology 
hospital where only children referred for radiotherapy or chemotherapy were seen.3
O.P.Kureshtra et al presented a study consisting  of 104 cases seen over the last 20 years 
.Benign primary tumors consisted 48 ,malignant (primary)22, malignant (metastatic)3,extensions from 
paranasal sinuses malignant 25,benign 1,extension from the cranial fossa .4 
Robert Kennedy reviewed 820 clinical orbital cases over a 34 year period, which include biopsy 
proven (450) and other clinical cases .These were patients seen by ophthalmologists practicing in an 
average community area rather than a large referral center and thus may be truly representative of what 
might be encountered in practices. This study included cases which were biopsy proven and also cases 
which were diagnosed without biopsy when there was strong medical, xray, or computerized 
tomography evidence Trauma, lymphoma, dermoid and idiopathic orbital inflammation were the most 
common diagnoses. 5
 Jerry Shields et al reviewed 645 consecutive biopsies of orbital lesions performed at a major 
ophthalmic hospital during a 20 year period .Their series of 645 specimens included dermoid, 
dacryoadenitis, reactive lymphoid hyperplasia and lymphoma as the most common lesions. This study 
included a group of primary orbital melanocytic tumors which were absent in the other studies.6
Between 1977 and 1984, 84 cases of orbital tumors with histological basis were analyzed at 
Chang Gung memorial hospital, Taiwan. There were cases with primary orbital tumors (70.2%), 
secondary orbital tumors (27.4%), and metastatic orbital tumors (2.4%).The most common primary 
orbital tumor was the dermoid cyst and hemangioma .Adenexal squamous cell carcinoma, 
retinoblastoma, and mucocoele were the secondary tumors .Nasopharyngeal cancer in secondary orbital 
tumor was also common.7
Vijayalakshmi Ammal reviewed 212 cases of orbital tumors of which 84 cases were 
neurofibromas and 64 were lacrimal gland tumors in 1990.8
Sylvia et al reviewed cases of histopathologically verified orbital tumors in children to 
determine the distribution of various pathological processes and trends over time .The medical records 
and pathology specimens from 340 patients aged 18 years or younger who under went biopsy from 
orbital mass in 1932 to 1991 were reviewed. The most common tumors were cysts, vascular lesions 
optic nerve and meningeal neoplasms. The overall frequency of malignancy was 18.2%of which 
11.5%were primary tumors and 6.8 % were secondary. 9
Henderson summarized his clinical experience at the Mayo clinic .He had a total of 
1376 cases over a time period of 18 years ,and his cases were from surgically excised 
specimens and angiographic  findings  in  case  of  vascular  malformations.  Mucocoele, 
lymphoma, squamous cell carcinoma, and meningioma were the most frequent lesions in 
his review.10 
Wilson et al reviewed 312 orbital lesions accessioned in their laboratory between 1942 and 1993 
.Orbital invasion of uveal melanoma, idiopathic orbital inflammation and dermoid were the most 
common lesions in their series.11
Demirci, Hakan et al in 2002 reviewed approximately 950 cases of orbital space occupying 
lesions in the older adult population. The orbital tumor was unilateral in 183 patients and bilateral in 17 
patient’s .The most common clinical features included mass proptosis and pain .The most common 
diagnosis were malignant lymphoma, idiopathic orbital inflammation and cavernous hemangioma.12
Jerry shields et al reviewed 1264 consecutive patients with orbital tumors and stimulating 
lesions referred to an ocular oncology center .In this series 64% were benign and 36% were malignant. 
The most common diagnosis was lymphoid tumor, idiopathic orbital inflammation and cavernous 
hemangioma.13 
PERSPECTIVE OF 
ORBITAL TUMORS
CLASSIFICATION OF 
ORBITAL TUMORS
 CLASSIFICATION   OF    ORBITAL   TUMORS
According to Grossniklaus, the orbital disorders can be classified into (I) Systemic (II) 
Inflammatory (III) Trauma (IV) Congenital (V) Primary neoplasms (VI) Secondary neoplasms (VII) 
Metastasis (VIII) Vascular (IX) Others. Tumors were classified into primary, secondary and metastatic. 
Primary tumors were further classified into  2 
 EPITHELIAL   
 BENIGN MIXED TUMOR
 MALIGNANT MIXED
 ADENOID CYSTIC CARCINOMA
 SPINDLE CELL CARCINOMA
 ADENO CARCINOMA
 MUCOEPIDERMOID CARCINOMA
 LYMPHOEPITHELIOMA
 CONJUNCTIVAL CYST
 SUDORIFEROUS CYST
 FIBROUS CONNECTIVE TISSUE         
 FIBROMA
 FIBROSARCOMA
 FIBROUS HISTIOCYTOMA
 MYXOMA
 FIBROMATOSIS
FIBROOSSEOUS  
 OSTEOMA
 OSTEOSARCOMA
 FIBROUS DYSPLASIA
 OSSIFYING FIBROMA
 PAGET’S DISEASE
 ANEURYSMAL BONE CYST
 FIBROOSTEOMA
 EWING’S SARCOMA
CARTILAGENOUS  
 CHONDROMA
 CHONDROSARCOMA
ADIPOSE  
 LIPOMA
 LIPOSARCOMA
VASCULAR  
 CAPILLARY HEMANGIOMA
 CAVERNOUS HEMANGIOMA
 LYMPHANGIOMA
 HEMANGIOPERICYTOMA
 HEMANGIOENDOTHELIOMA
 ANGIOLEIOMYOMA
 FIBROANGIOMA
 GLOMANGIOMA
MUSCLE  
 RHABDOMYOMA
 RHABDOMYOSARCOMA
NEURAL  
 MENINGIOMA
 NEUROFIBROMA
 GLIOMA
 NEURILEMMOMA
 MALIGNANT PERIPHERAL NERVE SHEATH  TUMOR
 ASTROCYTOMA
 EPENDYMOMA
 GRANULAR CELL MYOBLASTOMA
MALIGNANT LYMPHOMAS  
 LYMPHOID HYPERPLASIA
 WELL DIFFRENTIATED LYMPHOCYTIC TYPE
 POORLY DIFFRETIATED LYMPHOCYTIC TYPE
 HODGKINS DISEASE
 RETICULUM CELL TYPE
OTHER TUMORS OF RETICULUM CELL PROGENY  
       HISTIOCYTOSIS
 INFANTILE XANTHOGRANULOMA
 PLASMA CELL DYSCRASIAS
 LEUKEMIA
SECONDARY NEOPLASMS  
 INVADE THE ORBIT FROM ADJACENT STRUCTRES INCLUDING 
THE EYE AND OCULAR ADENEXA, PARANASAL SINUSES, ORAL 
CAVITY AND CRANIUM.
METASTATIC TUMORS  
 TUMORS  METASTAZISING TO THE ORBIT
ORBITAL TUMORS
VASCULAR
CAPILLARY HEMANGIOMA23
DEFINITION  :  Common benign hamartoma (mass of disorganized but mature specialized cells or 
tissue indigenous to the particular site) of orbital & periorbital areas in childhood. INCIDENCE:  1-2% 
of orbital tumor. AGE/SEX: Usually presents in first few months of life (95% by 6 months of age), but 
never at birth with female preponderance. CLINICAL FEATURES :  Mainly of 3 types being 
Superficial type presenting as “strawberry nevus”, deep variety in orbit giving rise to proptosis and 
combined variety. HISTOLOGY:  It is composed of endothelial & capillary vessel proliferations with 
benign endothelial cells surrounding the small capillarised vascular spaces. RADIOLOGY: On CT-
Scan, appears fairly well marginated or poorly marginated, irregular enhancing lesions. On MRI, 
appears hypo or slightly hyper intense to brain in T1 weighted images and hyper intense in 
T2.MANAGEMENT  :  Indicated in cases of amblyopia, optic nerve compression, exposure keratitis or 
cosmetic blemish with necrosis. It includes intralesional steroids, systemic steroids, alpha-interferon, 
local resection & low dose radiotherapy.
CAVERNOUS HEMANGIOMA24
DEFINITION:  Type  of  developmental  polymorphic  vascular  hamartoma  commonly 
seen in adults. . Most are located within the muscle cone. 
INCIDENCE: 1-2% of orbital tumour.AGE GROUP: 1st to 8th decade. Mainly in middle aged women 
(M: F=1:3) .CLINICAL PRESENTATION: Unilateral, painless, gradually progressive axial 
proptosis usually asymptomatic. Can cause decreased vision due to optic nerve compression or induced 
hyperopia, amaurosis due to intermittent optic nerve compression. HISTOLOGY  :   Well-
circumscribed, well encapsulated, mulberry like, spongy , reddish brown colored mass On cut-section
—large blood-filled spaces. RADIOLOGY: CT-scan: Well-defined, rounded, intraconal mass with 
smooth margin, with uniform homogenous enlargement on contrast. They do not deform the globe. 
Serial dynamic MRI shows connecting point of tumor to the feeder vessel in early stage (50 sec). In 
T-1image:  iso intense with muscles. In T-2 image, hyper intense to fat and muscles. 
MANAGEMENT: Surgical excision in symptomatic patients and the common site being intraconal, 
lateral orbitotomy is the surgery of choice.
LYMPHANGIOMA25
DEFINITION  :  Benign vascular malforma tions, which are abortive and nonfunctional. . This lesion is 
seen most frequently in young children.This lesion may wax and wane in size, especially when the 
child has an upper respiratory infection(reflecting the proliferating lymphoid elements in the connective 
tissue trabeculae of the tumor).  INCIDENCE: Less than 7% of patients with childhood orbital tumors 
AGE/SEX  :  Mainly in 1st two decades of life, M: F=1:3.CLINICAL FEATURES  :  If anterior in orbit, 
multiple small bluish masses in superonasal quadrant of orbit. If posterior, it causes slowly progressive 
proptosis ,which spontaneously become painful, due to hemorrhage in tumor it will form “chocolate 
cysts” which will resolve with time. MICROSCOPY: Non encapsulated networks of endothelially 
lined channels, separated by thin septae and filled with pale-staining lymph. RADIOLOGY  :  Poorly 
circumscribed heterogeneous masses of increased density in extra & intraconal space. Fluid-fluid levels 
related to hemorrhages of various stages are best seen in MRI MANAGEMENT: Persistent sight-
threatening chocolate cysts should be drained or removed sub totally by controlled vaporization of CO2 
laser, otherwise conservative treatment is gold standard.
HEMANGIOPERICYTOMA/HEMAGIOENDOTHELIOMA26
DEFINITION: Group of tumors with rich vasculature. In Haemangiopericytomas, where 
capillaries consisting of endothelial channels surrounded by proliferation of contractile 
pericytes of Zimmerman. In Haemangioendothelioma there are both locally aggressive 
and  capable  of  metastasis  where  it  is  called  malignant 
haemangioendothelioma.INCIDENCE  :  About 15-30% of hemangiopericytomas occur 
in the head and neck region. haemangioendothelioma compose less than 1% of all soft 
tissue sarcoma .AGE  / SEX  :  The tumor can appear in persons of any age, with 80-95% of 
patients older than 20 years. ). Approximally 10% of hemangiopericytomas are found in 
children  .Males=Females.CLINICAL    PRESENTATION  :  About  50% cases  are  malignant 
having potential for distant spread. In orbit, generally presents as non tender, irreducible 
and  non-pulsatile  proptosis,  superior  orbit  and  intraconal  location  being  common. 
Capable  of  metastasizing  to  distant  organs  .In  striking  contrast  to  cavernous 
hemangioma, these cause puffiness of the eye lids with bluish discoloration of the ocular 
adenexa.PATHOLOGY: Histopathologically  it  may  assume  one  of  3 
configurations:1)A  prominent  vascular  pattern  of  sinusoidal  spaces,2)An  ostensibly 
solid pattern in which the vasculature may not be seen.3)A combination of the two. 
Vascular  pericytes  are  of  mesenchymal  origin  that  spiral  around  capillaries  and 
postcapillary venules. The tightly packed cells around the thin-walled blood vessels are 
lined by flattened endothelial cells. Hemangiopericytomas  contain periodic acid schift 
and  reticulin-staining  basement  membrane  material.RADIOLOGY:  Orbital  CT Scan 
documents  a  round  to  oval  mass  usually  located  in  the  superior  orbit.The  well-
encapsulated lesion,with its large arterial feeding vessels,exhibits dramatic enhancement 
on injection of contrast  material.  Slightly  less distinct  margins is due to invasion of 
adjacent tissues.Erosion of underlying bone and marked contrast enhancement are key to 
diagnosis.On MRI ,these well-delineated tumors are hypointense to fat on T1-weighted 
images  and  hyperintense  to  fat  and  isointense  to  vitreous  on  T2-weighted  images. 
MANAGEMENT  :  Optimal treatment is wide excision with negative margins. Tumor 
cells  may be left  behind with enucleation.  For  unresectable  or  incompletely  excised 
tumors, radiotherapy has an important role. 
FIBROUS CONNECTIVE TISSUE
FIBROMA28
DEFINITION  :  It is a true benign neoplasm of bone originating in the mesenchymal tissue of 
periosteum. INCIDENCE: 4%-6% AGE/SEX: Younger patient,7-18 years (average 13) 
CLINICALPRESENTATION: Slowly progressive painless proptosis. Orbital plate of frontal and 
spheno ethmoidal bone commoly affected. It consists of units of lamellar bone which show clear-cut 
lines or lamellae on polarization. Osteoblastic activity is present.HISTOPATHOLOGY: Usually tan-
gray colored whitish red tissues with soft fibrous texture having grittiness depending on osteoid 
formation.  Highly cellular fibroblastic stroma  interspersed with bony spicules forming osseous 
trabeculae rimmed by osteoid which is again rimmed by osteoblasts.Typically shows ”zonation 
phenomenon” showing more mature osteoids towards periphery.RADIOLOGY: CT shows a mass with 
less radiodense centre with scattered calcifications with sclerotic margin, more delimited than fibrous 
dysplasia. MANAGEMENT: Wide local excision.
FIBROUS HISTIOCYTOMA29
DEFINITION- Malignant fibrous histiocytoma (MFH), described by O'Brien and Stout in 1964, is the 
most common soft tissue sarcoma of late adult life due to fibroblastic proliferation involving fascia, 
muscles and soft tissues .INCIDENCE- MFH accounts for 20-24% of soft tissue sarcomas, making it 
the most common soft tissue sarcoma occurring in late adult life.AGE/SEX- The tumor occurs with a 
peak incidence in the fifth and sixth decades but an age range of 10-90 years is reported. Although the 
tumor is rare in children, the angiomatoid subtype is the most frequently occurring variety in patients 
younger than 20 years. Male-to-female ratio is approximately 2:1. CLINICAL PRESENTATION-
Slowly growing proptosis with growth in superonasal quadrant of orbit, with congestion, chemosis, lid 
retraction, motility disturbances and occasionally compressive neuropathy. PATHOLOGY: The 
tumor contains both fibroblast like and histiocyte like cells in varying proportions, with spindled and 
rounded cells exhibiting a storiform arrangement. Five histologic subtypes have been described 
including (1) storiform/pleomorphic (most common), (2) myxoid, (3) giant cell, (4) inflammatory 
(usually retroperitoneal), and (5) angiomatoid (often located more superficially than other 
varieties).RADIOLOGY-CT shows well-circumscribed mixed density tumor with heterogeneous 
enhancement and intact bones. USG reveals a high tissue reflectivity and heterogeneity. Benign lesions 
will show compressive bone remodeling. MANAGEMENT-Benign-surgical excision. Malignant- 
Exentration and radiotherapy /chemotherapy.
OSSEOUS
OSTEOMA30
DEFINITION  :  Osteoid osteoma is a benign skeletal neoplasm of unknown etiology that is composed of 
osteoid and woven bone. INCIDENCE: Accounted for 12.1% of benign tumors and 2.9% of all tumors 
10%-15%AGE/SEX  :  Three quarters of patients are in age 10-30 years, and more than 90% of patients 
are aged 5-25 years. The age range in patients is 5-56 years. The male-to-female ratio is 2:1. 
CLINICAL   PRESENTATION  : Focal skeletal bone pain, which worsens at night and is frequently 
relieved with a small dose of aspirin. Nonaxial Proptosis. Frontal and ethmoidal sinuses involvements 
are the most common presentation in and around orbit. PATHOLOGY: The tumor consists of an 
ovoid or spherical nidus of osteoid-rich tissue and interconnected bone trabeculae superimposed on a 
background of highly vascularized connective tissue containing large dilated vascular channels. 
RADIOLOGY: CT shows hyperdense, rounded or multilobular lesion projecting into the orbit. 
MANAGEMENT: Surgical excision. ASSOCIATIONS: Turcot’s syndrome , Gardner’s syndrome.
CHONDROMA31
DEFINITION  :  Enchondromas are benign cartilaginous neoplasms in bone. . In orbit it envolves 
trochlear cartilage. INCIDENCE: Enchondromas account for 12-14% of benign bone neoplasms and 
3-10% of osseous neoplasms in general. AGE/SEX: Solitary enchondromas most often are 
discovered in those aged 20-40 years.  Enchondromas occur equally in males and females.CLINICAL 
PRESENTATION: Slowly progressive painless proptosis. Typically located in superonasal quadrant 
and attached to medial orbital wall. HISTOLOGY: Enchondromas are ectopic hyaline cartilage 
rests in intramedullary bone hypocellular population of cells of hyaline cartilage that are 
widely dispersed singly in lacunae. RADIOLOGY: The lesions replace normal bone with 
mineralized or unmineralized hyaline cartilage, thereby generating a lytic pattern on 
radiographs or a lytic area containing rings and arcs of chondroid calcifications. 
MANAGEMENT:  Wide local excision
OSSIFYING FIBROMA28
DEFINITION:  Osteofibrous dysplasia which occurs exclusively in adults commonly is referred to as 
ossifying fibroma. INCIDENCE:  Osteofibrous dysplasia usually is first diagnosed in children with a 
peak incidence occurring in children aged 1-5 years.  AGE/SEX: The age range at the time of 
diagnosis has been variable in the literature.No significant sex preponderance consistently has been 
reported. CLINICAL PRESENTATION: Slowly progressive painless proptosis. Orbital plate of 
frontal and sphenoethmoidal bone most commonly affected.
PATHOLOGY: Highly cellular fibroblastic stroma containing interspersed with bony 
spicules  forming  osseous  trabeculae  rimmed  by  osteoid  which  is  again  rimmed  by 
osteoblasts.  Typically  shows,”Zonation  phenomenon” showing more  mature  osteoids 
towards periphery.RADIOLOGY: Osteofibrous dysplasia is an eccentric, intracortical, 
osteolytic  lesion.  CT  shows  a  mass  with  less  radiodense  centre  with  scattered 
calcifications with sclerotic margin..MANAGEMENT: Due to the high recurrence rate, 
nonoperative treatment of the lesion until after skeletal maturity is reached, at which 
time marginal resection and bone grafting may be performed without increased risk of 
recurrence. 
MUSCLE
RHABDOMYOSARCOMA32
DEFINITION: Rhabdomyosarcoma (RMS) (from Greek, rhabdo, meaning rod shape, and myo, 
meaning muscle) is the most common soft tissue sarcoma in children which arises from 
undifferentiated mesenchyme rather than differentiated striated muscle.Pre-existent radiotherapy, germ 
line mutation of p53 suppressor gene(Li-Fraumeni Syndrome), translocation (2;13), 
(q35;q14).INCIDENCE: 6:1,00,000 per year. 5% of childhood malignancies, 50% of all paediatric 
sarcomas and 15% of all paediatric solid tumors. 44% in head and neck-   25%-60% of these originate 
in orbit. AGE/SEX: Approximately 87% of patients are younger than 15 years, and 13% of patients are 
aged 15-21 years. RMS rarely affects adults. In patients with orbit RMS, 42% are aged 5-9 years 
Bimodal age distribution, with higher .prevalence in children, average age being 7 years (Embryonal & 
Alveolar) whereas Pleomorphic type is common in adults. Overall, the male-to-female ratio is 
1.2-1.4:1. Differences exist according to the site of primary disease.In orbit: The male-to-female ratio is 
0.88:1. CLINICAL   PRESENTATION  : Acute onset of painless, rapidly progressive proptosis. 
Swelling and ptosis of upper lid caused by a palpable mass usually in upper quadrant. PATHOLOGY  :  
RMS is one of the small, round, blue cell tumors of childhood. RMS cells may 
demonstrate positive immunohistochemistry results for muscle-specific markers, such as 
myoglobin, actin, and desmin. Cells from the RMS subtypes have the following 
distinctive features: (1) Botryoid: The cambium layer is characteristic, containing a 
condensation of loose tumor cells below an epithelial surface. (2) Alveolar: Cells line up 
along membranes that may be imperceptibly thin or may be obvious collagen bands, 
resembling the lung alveoli. Alveolar has worst prognosis (3) Undifferentiated: Usually, 
no evidence of myogenesis differentiation is present. RADIOLOGY  :  CT shows enhancing 
mass within the orbit with bone destruction in larger tumors. Its usually isointense in relation to normal 
muscles, appears homogenous, well-defined soft tissue masses without bone damage. MRI: T1 
weighted appears isointense or slightly hypointense compared to brain and appears hyperintense on fat 
suppression. T2 images shows increased signal intensity.MANAGEMENT: Incision biopsy followed 
by chemotherapy and /or radiotherapy.
NEURAL
MENINGIOMA33
DEFINITION  :  Tumor arising from meningothelial cap cells of arachanoid matter of optic nerve. 
INCIDENCE: It is approximately 20% of all intracranial tumors; population-based studies indicate an 
overall incidence of 2.3 cases per 100,000.AGE/SEX: In children, the male-to-female ratio is 2:1, with 
an average age at presentation of 10.1 years (range 1-16 y). The incidence of meningiomas increases 
with age, 2-7 cases per 100,000 in women and 1-5 cases per 100,000 in men. Peak incidence is in the 
seventh decade in women and in the eighth decade in men. Meningiomas rarely occur in 
infants.CLINICAL   PRESENTION  :  Profound visual loss evolves over decades & early loss apparent 
only with threshold perimetry. Occasionally patient may present with proptosis. MICROSCOPY  :  The 
macroscopic appearance of meningiomas may be hemispheric, bun-shaped, or globular. 
They usually are attached to the dura and invaginate into adjacent neural structures. 
Enveloped in a thin capsule derived from the adjacent meninges, they remain extraaxial 
and are separated easily from the brain or the spinal cord. RADIOLOGY: CT shows two 
morphologic types: En plaque- a focal exophytic tumor along the course of intraorbital segment with 
enhancement. Fusiform- tumor is denser than normal nerve & shows “rail-road track” sign produced by 
calcification. ONSM is confined to the dura mater; therefore, it often appears as a distinct, fusiform 
thickening of the optic nerve. This enlargement may appear as localized or as an eccentric expansion of 
the optic nerve, and it occurs most commonly at the orbital apex.On MRI, tumor is hyperintense on T1 
& T2 weighted images.  Although an MRI most readily shows the soft tissue tumor characteristics of 
ONSM, a CT scan better displays any associated bony hyperostosis.MANAGEMENT: Patients with 
ONSM can be observed if there is no evidence of intracranial extension, vision loss, or visual field loss. 
Treatment with primary radiation or radiation following surgical removal has been associated with a 
better chance of visual improvement. Chemotherapy is reserved for patients with unresectable, 
recurrent, or previously irradiated meningiomas. Combination treatment with 5-fluroouracil, folate, and 
levamisole, or a combination of intraarterial cisplatin with intravenous doxorubicin, may be beneficial. 
OPTIC NERVE GLIOMA34
DEFINITION  :  They are juvenile pilocytic astrocytoma, fusiform, ordinarily benign enlargement of 
optic nerve contained within an intact dural sheath. INCIDENCE : Optic nerve gliomas represent 4% 
of orbital tumors, 4% of intracranial gliomas, 2% of intracranial tumors and two thirds of all primary 
optic nerve tumors.AGE/SEX: In the pediatric population, the median age of patients is 5 years, and 
80% of patients present prior to age 15 years . In adult patients, age ranges from 22-79 years, with a 
mean age of 52 years . In pediatric patients, a slight female predominance is found, while in adult 
patients, a slight male predominance is found.CLINICAL   FEATURES  :    The presenting symptom is 
painless proptosis. Optic atrophy is common When the lesions are large, local compressive effects may 
result in optic chiasm symptoms such as nystagmus. Hypothalamic symptoms, such as changes in 
appetite or sleep, also may occur. When lesions are massive, compression of the third ventricle may 
occur,resulting in obstructive hydrocephalus with headache,nausea, and 
vomiting.HISTOPATHOLOGY: consists of spindle cells with frequent mucinous changes.rosenthal 
fibres are pathognomic with fibrillary astrocytes positive for phosphotungstic acid hematoxylin and 
glial fibrillary acidic protein.  RADIOLOGY: In children, unenhanced CT typically reveals a marked 
diffuse enlargement of the optic nerve, with characteristic kinking or bending. The enlargement may be 
tubular, fusiform, or excrescent. Areas of lucency may be observed as a result of mucinous or cystic 
changes. Approximately 50% of the lesions demonstrate enhancement, and enhancement is more 
common with intracranial (especially retrochiasmatic) extension. Calcifications are rare. MRI shows 
hypotense or isotense lesion on T1 & hyperintense on T2 weighted images. Enlargement of optic canal. 
MRI shows hypotense or isotense lesion on T1 & hyperintense on T2 weighted images. Intracranial 
extension better appreciated on MRI. MANAGEMENT: Guided by location of the tumor & visual 
potential. Usually observation with monitoring of optic nerve function & disc edema 3 monthly 
.Surgery is the main stay of treatment. 
NEUROFIBROMA35
DEFINITION:      Orbital neurofibroma is usually an isolated tumor of nerve cells, and is not 
associated with neurofibromatosis. Orbital neurofibroma that is associated with neurofibromatosis also 
occurs, and this type is typically the plexiform neurofibroma, which begins in the eyelid.  Consits of a 
mixture of Schwann’s cells, peripheral nerve axons, endoneural fibroblasts & perineural cells. ssociated 
with neurofibriomatosis-1 which is an autosomal dominant inherited trait. INCIDENCE  :  0.5%-2.4% of 
orbital tumors. AGE/SEX  :  Localised neurofibroma in young to middle-aged patient and diffuse and 
plexiform neurofibroma make their appearance within first decade of life.CLINICAL 
PRESENTATION: Three types: Isolated neurofibromas, plexiform, diffuse. Isolated NF presents a 
painless of mildly painful proptosis caused by an orbital soft tissue mass in superior quadrant 
commonly. It’s a non-encapsulated-has compression pseudocapsule-white to tan colored tumor. In 
Plexiform and Diffuse NF patient  presents with massive overgrowth of lids along with similar 
infiltration of orbit and facial tissues, In the first there is vermiform collection of molluscusm,Lisch’s 
nodule,axillary freckle etc. In Plexiform, tissues are expanded by recognizable neural units whereas 
Diffuse form observes a monotonous spindle cells proliferation. MICROSCOPY  :  Consists of wavy 
cells typically dispersed in small bundles. In Plexiform and Diffuse neurofibromas, patient presents 
with massive overgrowth of lids along with similar infiltration of orbit and facial tissues, in the first 
there is vermiform collection of individual units on palpation not in the later. Other features are café-
au-lait spots, fibroma molluscusm, Lisch nodule, axillary freckling. In Plexiform, tissues are expanded 
by recognizable neural units whereas diffuse form observes a monotonous spindle cell proliferation. 
RADIOLOGY: In isolated form CT reveals a homogenous well-circumscribed soft tissue density that 
has uniform contrast medium enhancement. MRI shows lesions hypointense to isointense on T1 and 
hyperintense on T2 weighted images. In plexiform neurofibromas, CT shows moderately enhancing 
soft tissue density without clearly defined borders. May show absence of sphenoid 
wing..MANAGEMENT  :  Surgical excision in localized form. In plexiform and diffuse , cosmetic 
debulking using CO2 laser.
NEURILEMOMA36
DEFINITION: A pure proliferation of Schwann’s cells. Orbital schwannomas are usually isolated 
lesions, except when they are associated with neurofibromatosis type 2 (NF2), a rare autosomal 
dominant disorder occurring in approximately 1 live birth in 50,000. NF2 is also called the multiple 
inherited schwannomas, meningiomas, and ependymomas (MISME) syndrome. It arise from the nerve 
sheath ,consist of Schwann cells in a collagenous matrix.INCIDENCE: Schwannomas account for 
6-8% of intracranial neoplasmsAccounts for 1% of all orbital tumors.  Are found in 1.5% of patients 
with NF1. AGE/SEX: Young to middle aged adults. No sex predilection has been 
described.CLINICAL   PRESENTATION  : Produce slowly progressive painless proptosis. 
HISTOPATHOLOGY:   They are extremely encapsulated, have smooth surface & friable. Usually 
appears yellowish-tan colored, solid, encapsulated with varicose, violaceous tumor vessels on surface. 
They have both solid and myxoid areas alternate with each other in varying proportion. Spindle-cells 
oriented in fascicles, with long axis parallel to each other called Antoni Type A., in type B it is 
haphazardly arranged. RADIOLOGY: CT shows a homogenous well-circumscribed soft tissue mass. 
On nonenhanced CT scans, most schwannomas are isoattenuating relative to brain parenchyma. 
Calcification or areas of hemorrhage are rare. Long standing lesions may produce remodeling or frank 
erosion of bone. MRI shows a discrete,homogenous soft tissue density that is hypointense on T1 and 
hyperintense on T2 weighted images. The cystic spaces can result in high signal intensity on T2-
weighted MRIs. Gadolinium enhancement is typically homogeneous, although larger schwannomas can 
show areas of cystic degeneration and heterogeneous signal intensity; these findings are based on 
increased numbers of areas with Antoni type B histologic features. MANAGEMENT: Stereotactic 
radiosurgery (ie, gamma knife radiosurgery) largely has replaced surgical resection for the treatment of 
vestibular schwannomas, particularly when the lesions do not compress the brainstem. Lesions should 
be smaller than 3 cm. Studies have demonstrated rates of tumor control (ie, lesion stabilizes or shrinks) 
of greater than 95% and a rate of hearing preservation of approximately 70%. Although less well 
studied, other CN schwannomas also can be treated with radiosurgery
MALIGNANT LYMPHOMAS  37  
DEFINITION : These are solid tumors of immune system composed of monoclonal B-
cells.  It mimics Non-Hodgkin’s lymphoma. The lacrimal gland is the most frequent site 
of  involvement  in  the orbit.  It  may be  either  due to  systemic  disease(75%) or  may 
indicate primary site.  Bilateral involvement can also be seen.  2 parts in orbit having 
lymphoid tissue,  i.e.  substantia  propria  of  conjunctiva & lacrimal  glands,account for 
lymphoreticuloses  of  orbit  .Of  all  the  patients  of  orbital  lymphoma,75%  will  have 
systemic disease. INCIDENCE  ;  Almost up to 10-15% of orbital masses are extranodal 
NHL.AGE  / SEX  :  Rarely  in  children.Mainly  in  6-7 decade of  life  with slight  female 
preponderance.  CLINICAL PRESENTATION: They usually occur in anterior orbit 
with pink, fleshy, sub conjunctival tumefaction (salmon patch), tends to mould to the 
shape of globe. On palpation they are nodular with well-defined margins and slightly 
friable  texture  with  rich  vascularity  intra  operatively.  Roughly  75%  lesions  are 
unilateral. It produces painless progressive non axial proptosis, visual disturbances & 
lacrimal gland enlargement Any pt of orbital lymphoma should be subjected to systemic 
evaluation to rule out systemic lympho proliferative disorder. PATHOLOGY:The cells 
are monotonous with a high nuclear-to-cytoplasmic ratio.Nuclei often are convoluted 
with  finely  stippled  chromatin;  nucleoli  usually  are  visible  but  not  prominent. 
Immunohistochemical  analysis  reveals  T-cell  markers,including  CD5  and 
CD7.RADIOLOGY: They  are  homogenous  masses  with  relatively  high  density  & 
sharp margins, mainly in anterior orbit, superior orbit or retrobulbar area. It shows putty 
like molding of tumor to preexisting structures without eroding the bone or expanding 
the orbit. Lacrimal gland lymphoma displaces the globe medially & forward. The optic 
nerve lymphomatous infiltration shows tram-like (axial) and ring (coronal) enhancement 
after  IV  contrast  which  is  also  noticed  in  meningiomas  and  sarcoidosis. 
MANAGEMENT: Low dose radiotherapy and chemotherapy for systemic cases.
TUMORS OF RETICULUM CELL ORIGIN  37  
Histiocytosis X or Langerhans’ cell histiocytosis
DEFINITION + CLASSIFICATION: A group of histiocytic proliferative disorders derived from 
dendritic types of cells derived from bone marrow, epidermis, brain & oral mucosa.Mainly classified 
into 3 groups [1].Eosinophilic granuloma (self limited, benign) [2].Hand-Schuller-Christian Disease 
(Multi focal with systemic involvement) [3].Letterer-Sewe Disease( Acute , disseminated 
disease ).INCIDENCE: Comprises 7% of orbital tumors in children and <1% of total orbital tumors. 
AGE/SEX : Mainly in early childhood , 1 to 3 years of age with M:F=3:1.CLINICAL 
PRESENTATION: [1]. Eosinophilic granuloma - comprises 70% of all histiocytosis, mainly solitary, 
orbital mass with painful ,tender, erythematous swelling at anterior & superotemporal orbit causing 
proptosis. Skull bones are the commonly involved with frontal & parietal being commonest. [2]. Hand-
Schuller-Christian Disease - comprises 20% of all histiocytosis, with equal sex distribution. It presents 
as multifocal bony lesions with hepatosplenomegaly, lymphadenopathy, malaise, anorexia, fever & 
classical triad of exophthalmos, diabetes insipidus & bony destructions.[3]. Letterer-Sewe Disease —
comprises 10% of histiocytosis, with acute, disseminated histiocytosis in infants<2yrs.It shows 
hemorrhagic papules of skin, spleenic & hepatic involvement, pancytopenia with poorest 5 year 
survival (<50%).Orbital involvement is very rare here. HISTOPATHOLOGY:Usually the tumors are 
soft, friable, hemorrhagic & tan-yellow colored. Microscopy shows large Langerhans histiocytic cells 
(15-25 microns) with round to indented nuclei and marked nuclear folds resembling coffee beans. 
Typical rod-shaped, tubular, tennis racquet shaped cytoplasmic inclusions called Birbeck granules are 
diagnostic on electron microscopy. Immuno histochemical markers are nuclear membrane S-100 
protein & cell-surface and cytoplasmic marker called CD1a (OKT-6). RADIOLOGY: Bone 
involvement is characterized by irregular lucent patches with cortical destruction but without any 
sclerosis. In orbit mainly the superotemporal part shows pathology. MANAGEMENT: For localized 
disease, localized curettage with intralesional steroids followed by low dose radiation and systemic 
steroids. For disseminated diseases, chemotherapy is a must. 
Granulocytic sarcoma (Chloroma)
DEFINITION: Extra medullary form of Acute Myeloblastic Leukemia INCIDENCE: It occurs in 
about 3% of all AML patients.AGE/SEX: Mean age of onset is 7 years with Male preponderance (3:2) 
and non-Caucasian population. CLINICAL FEATURES: As orbit being the site of initial presentation 
showing involvement of soft tissues, lacrimal glands & bones. The lesion typically involves 
subperiosteal space of lateral orbital wall with extension into temporal fossa. HISTOPATHOLOGY: 
Typical greenish hue of tumor is due to enzyme of tumor cells. Cells of myeloid origin are best seen by 
Leder stain for chloroacetate esterase. RADIOLOGY: Depending on area of infiltration, mainly 
subperiosteal space of superotemporal quadrant with proptosis. MANAGEMENT Radiotherapy and 
chemotherapy.
INTRINSIC NEOPLASMS OF THE LACRIMAL GLAND  38  
PLEOMORPHIC ADENOMA
DEFINITION  :  Is a benign mixed-cell tumor and most common epithelial tumor of lacrimal gland. It is 
derived from ducts, stroma, and myoepithelial elements.INCIDENCE: It is the most common epithelial 
tumor of lacrimal gland. Epithelial neoplasms account for only 4% of all lacrimal gland lesions. AGE/
SEX: Second to Fifth decade of life. M=F.CLINICAL PRESENTATION: Slowly progressive 
swelling in upper outer quadrant of more than 1 year duration and may cause non-axial proptosis. 
HISTOPATHOLOGY: firm, grayish-white bosselated and solitary masses.  Mixture of epithelium and 
connective tissue with pleomorphism. Pseudocapsule is present showing microscopic nodular 
extensions into pseudocapsule in 60% cases. RADIOLOGY: CT shows a round or oval smooth outline 
with excavation of lacrimal gland fossa with destruction with moderate to marked enhancement on CT 
and MRI.MANAGEMENT: Complete surgical excision without violating the capsule. Incisional 
biopsy of these lesions is contraindicated because, although histologically benign, incomplete excision 
often leads to repeated recurrences (as high as 30% in some studies) and malignant transformation. 
ADENOID CYSTIC CARCINOMA
DEFINITION: Most common malignant epithelial tumor of lacrimal gland. INCIDENCE: Adenoid 
cystic carcinoma is the most common malignant lacrimal gland tumor, comprising 50% of malignant 
tumors of lacrimal gland and 25% of all lacrimal gland-tumors.AGE/SEX: 4th to 6th decade.CLINICAL 
PRESENTATION: Proptosis of shorter duration (<10 months) and with pain associated with 
parasthesiae. HISTOPATHOLOGY: Derived from duct cells, and they form spaces into 
which basement membrane like material is deposited. This confers a cribriform or 
"Swiss cheese" appearance to the tissue. Five histologic patterns have been observed in 
these lesions, as follows: (1) cribriform (the most common subtype) (2) sclerosing, (3) 
basaloid, (4) comedo, and (5) ductal. The basaloid type has the worst 
prognosis.RADIOLOGY: CT shows large tumors, calcification with bony erosions having 
destruction of walls and pressure changes having expansion and lytic lesions of lacrimal fossa with 
micro serrations. MRI is useful to see perineural infiltration, cavernous sinus 
involvement.MANAGEMENT: Wide local excision followed by radiotherapy or brachytherapy 
SECONDARY NEOPLASMS  39  
DEFINITION:   Involves the orbit by direct extension and can arise in any of adjacent structures. Para 
nasal sinus, Nasopharyngeal, Lacrimal, Conjunctival, Eyelid, Intraocular, Intracranial tumors. 
INCIDENCE: 48%. AGE/SEX:   Most patients are diagnosed in their fifth or sixth decadeCLINICAL 
PRESENTATION: Patient presents may with chronic sinusitis, nasal obstruction, pain, non axial 
displacement of the globe, lower lid swelling, diplopia, blurred vision, epiphora. On examination, 
patient may have proptosis and displacement of the globe, congestion, chemosis, strabismus, decreased 
acuity, hypoesthesia, nasal mass. Squamous cell carcinoma is the most common sinus malignancy to 
involve the orbit these tumors arise from the maxillary sinus in most cases. Nasopharyngeal carcinoma 
may spread to the orbit through the inferior orbital fissure Retinoblastoma is the most common intra 
ocular tumor of child hood .The tumor reaches the orbit through the loose connective tissue 
surrounding the vessels and the nerves .On reaching the orbit, the tumor cells grow quickly as 
undifferentiated neuroblastic cells without Flexner Winter Steiner rosettes. 
TYPES OF SECONDARY ORBITAL TUMOURS:
Paranasal Sinus Tumours: Benign-Mucocele/Osteoma/Inverted papilloma
                          Malignant-SCC/ADC/ACC/SNUC/Melanoma/Esthesioneuroblastoma
Nasopharyngeal Tumours: SCC/Lymphoepithelioma
Lacrimal Sac Tumours: Epithelial tumours/Melanoma
Conjunctival Tumours: SCC/Melanoma
Eyelid Tumours: BCC/SCC/Seb cell Carcinoma
Intraocular Tumours: Uveal melanoma/Retinoblastoma
IntracranialTumours:Meningioma/Glioblastoma/Chordoma  
RADIOLOGY: CT scan of the paranasal sinuses with contrast is particularly important in the initial 
assessment of sinus malignancies due to the superior capability of the CT scan to demonstrate bony 
involvement.MRI of the paranasal sinuses with and without gadolinium.MRI also is very useful in 
determining the extent of sinus disease.MRI can be used to differentiate between inspissated secretions 
and tumor. MRI is useful in evaluating subtle soft tissue changes. MANAGEMENT: According to 
primary site and type of tumor. Can be wide surgical excision, exenteration, chemotherapy and 
radiotherapy.
METASTATIC TUMORS  39  
 DEFINITION: Invade the orbit by metastasizing from the primary site via heamatogenous or 
lymphatic spread.ETIOLOGY: In adults, breast -42%, lungs -11%, prostate -08%,melanoma-05%, 
unknown-11%.Paediatric tumors: Embryonal or undifferentiated sarcoma, Neuroblastoma, Ewing’s 
sarcoma, Wilm’s tumor. INCIDENCE: 10%-12%.CLINICAL PRESENTAION: In the child orbit is 
more frequently involved and the globe less often. Whereas in adults 70% of metastasis are ocular and 
only 30% are orbital. Orbital metastatic lesion usually presents with an abrupt onset of proptosis, 
external ophthalmoplegia and orbital pain. Metastases to the orbit most often have indistinct boundaries 
and are diffusely infiltrating.  RADIOLOGY: CT shows mass lesion and bone involvement. Osteolytic 
lesions caused by thyroid and renal cell carcinoma. Osteoblastic lesion caused by prostatic carcinoma.
MANAGEMENT: Observation, systemic hormonal or chemotherapy, radiation,surgical excision, 
exenteration. 
AIMS AND 
OBJECTIVES
The aims of the study is to
1. Study the demographic distribution of orbital tumors –age wise, sex wise and 
state wise.
2. Study the presenting complaints,  the presenting eye and the duration of the 
symptoms. 
3. Study the history of the associated symptoms and the presence of past  and 
family history
4. Study  the  clinical  features  like  the  visual  acuity,  puppilary  reactions  and 
fundus of the affected eye.  
5. Study the laterality of the tumor, type of proptosis, and degree of proptosis.
6. Study the associated clinical features of the affected eye.
7. Study the type of investigative modality used in the diagnosis of the tumor.
8. Study the treatment modality used in the treatment of the tumor.
9. Study the  classification  of  the  tumor,  the  nature  of  the  tumor  and  type  of 
tumor.
10. To compare the results got with that of international studies. 
  
PATIENTS AND 
METHODOLOGY
This prospective descriptive study has enrolled patients with orbital tumors, 
coming to the orbit clinic of a tertiary eye care centre from September 2003 to March 
2005.
Any case of orbital tumor that presented for the first time to the hospital was included 
in the study.
Follow up cases were excluded from the study thereby avoiding repetition.
The  orbital  tumors  were  diagnosed  based  on  the  proforma  given  below.  The 
diagnosis was based on clinical history and eye examination .Laboratory investigations 
as well as radiological investigations like X-ray, USG, CT scan were undergone by the 
patient as required .Histopathological examination using light microscopic examination 
of H and E stained slides after fixation, paraffin embedding and sectioning were done. 
Treatment of orbital tumors was also studied.
This  study  includes  orbital  tumors  diagnosed  both  by  clinical  methods  and  by 
investigations. 
RESULTS 
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The age wise distribution showed 20%in the 0-19 year age group, 27.3%in 20-39 year age 
group, 34% in the 40-59 year age group and 16.7% in the 60-89 year age group. 
The sex wise distribution of orbital tumors showed that in 49.3%of cases males were involved and in 
50.7 of cases females were involved.
The state wise distribution of the cases showed that 68% of cases were from Tamilnadu, 21.3% from 
Kerala, 8.7%from Andra Pradesh and 2% from other states.
Sex
74 49.3
76 50.7
150 100.0
Male
Female
Total
Frequency Percent
AFFECTED EYE
RIGHT
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50%
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The affected eye was the right eye in 47.3% of cases and the left eye in 
50% of cases .Both the eyes were involved in 2.7% of cases.
Defective vision
33 22.0
117 78.0
150 100.0
Present
Absent
Total
Frequency Percent
Double Vision
5 3.3
145 96.7
150 100.0
Present
Absent
Total
Frequency Percent
Drooping of eyelids
4 2.7
146 97.3
150 100.0
Present
Absent
Total
Frequency Percent
Pain
18 12.0
132 88.0
150 100.0
Present
Absent
Total
Frequency Percent
Protrusion of eye ball
93 62.0
57 38.0
150 100.0
Present
Absent
Total
Frequency Percent
Mass
48 32.0
102 68.0
150 100.0
Present
Absent
Total
Frequency Percent
Defective vision was present in 22% of cases, double vision in 3.3%, drooping of 
eyelids in 2.7%, pain in 12%, proptosis in 62% and a mass was felt in 32 %of cases. 
Affected Eye
71 47.3
75 50.0
4 2.7
150 100.0
Right Eye
Left Eye
Both Eye
Total
Frequency Percent
Descriptive Statistics
32 .2 72.0 11.005 16.0309
5 1.0 12.0 4.000 4.6368
4 1.0 12.0 6.625 6.2099
93 .2 120.0 17.147 24.3630
19 1.0 72.0 14.579 25.8442
48 .2 72.0 14.327 16.0925
0
Defective vision duration
Double Vision duration
Drooping of eyelids
duration
Protrusion of eye ball
duration
Pain duration
Mass duration
Valid N (listwise)
N Minimum Maximum Mean Std. Deviation
 The duration of symptoms was a minimum of 2 weeks for defective vision, protrusion of eyeball and 
mass respectively while it was 1 month for pain, double vision and drooping of eyelids. The maximum 
duration of symptoms 12 months for double vision and drooping of eyelids, 6 years for defective 
vision, pain and mass while it was 10 years for protrusion of eyeball.
VISUAL ACUITY
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Group visual acuity
Frequency Percent
6/6 – 6/18
6/24--6/36
6/60—3/60
<3/60
TOTAL
79
19
12
35
145
54.5
13.1
8.3
24.1
100
54.5%of patients had visual acuity between 6/6-6/18, 13.1% between 6/24-6/36,8.3% between 
6/60-3/60, while 24.1%had vision less than 3/60. 5 patients could not be examined because of their age.
Eye lids were normal in 72.7%of cases while it showed ptosis in 10% of cases, lagophthalmos in 2.7% 
of cases and other presentation in 13.3% of cases .2 cases could not be examined because one had a 
squamous cell carcinoma involving the orbit and the other had a basal cell carcinoma involving the 
orbit.
Conjunctiva was normal in 79.3% of cases while it was congested in 8% of cases ,chemosed in 8% of 
cases .Salmon patch was present in 1.3%of cases .5 cases could not be examined because of conjuntival 
involvement by the tumor.
Pupil reaction was normal in 72.7% of cases, absent in 4.7% of cases, RAPD was present in 18.7% of 
cases.6 cases could not be examined because of the involvement of the cornea by the tumor or the 
cornea was hazy.
Eye lids
109 72.7 73.6
15 10.0 10.1
4 2.7 2.7
20 13.3 13.5
148 98.7 100.0
2 1.3
150 100.0
Normal
Ptosis
Lagopthalmos
Others
Total
Valid
SystemMissing
Total
Frequency Percent Valid Percent
Conjunctiva
119 79.3 82.1
12 8.0 8.3
12 8.0 8.3
2 1.3 1.4
145 96.7 100.0
5 3.3
150 100.0
Normal
Congested
Chemosis
Salmon patch
Total
Valid
SystemMissing
Total
Frequency Percent Valid Percent
Pupil 
109 72.6 75.7
7 4.7 4.9
28 18.7 19.4
144 96.0 100.0
6 4.0
150 100.0
Present
Absent
RAPD
Total
Valid
SystemMissing
Total
Frequency Percent Valid Percent
Fundus was normal 71.3% of cases and abnormal in 22% of cases .6.7% of cases could not be 
examined because of no view of the fundus due to cataract, involvement of the eye by the tumor or 
hazy cornea.
Fundus
107 71.3 76.4 76.4
33 22.0 23.6 100.0
140 93.3 100.0
10 6.7
150 100.0
Normal
Abnormal
Total
Valid
SystemMissing
Total
Frequency Percent Valid Percent
Cumulative
Percent
LATERALITY 
U/L, 96
B/L, 4, 
U/L
B/L
37.3
40.7
22
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PERCENTAGE
AXIAL ECCENTRIC NO
PROPTOSIS
TYPE OF PROPTOSIS 
TYPE OF PROPTOSIS
LATERALITY
FREQUENCY PERCENTAGE
UNILATERAL
BILATERAL
TOTAL
144
6
150
96
4
100
Unilateral presentation was in 96% of cases and bilateral in 4% of cases
Axial proptosis was present in 37.3% of case and eccentric proptosis in 40.7% of cases. Proptosis was 
absent in 22% of cases. 
Degree of proptosis
1 1.8
6 10.7
8 14.3
16 28.6
2 3.6
12 21.4
3 5.4
3 5.4
1 1.8
3 5.4
1 1.8
56 100.0
1.00
2.00
3.00
4.00
5.00
6.00
7.00
8.00
9.00
10.00
17.00
Total
Frequency Valid Percent
Degree of proptosis ranged from a minimum of 1mm to a maximum of 17 mm.
Globe displacement
56 37.3 47.9
61 40.7 52.1
117 78.0 100.0
33 22.0
150 100.0
Axial
Eccentric
Total
Valid
NO PROPTOSIS
Total
Frequency Percent Valid Percent
MASS FELT 
PRESENT, 44
NOT FELT, 54
NOT 
EXAMINED, 2
PRESENT
NOT FELT
NOT EXAMINED
OCULAR MOVEMENTS
FULL, 40
RESTRICTED, 
58
NOT 
EXAMINED, 2
FULL
RESTRICTED
NOT EXAMINED
Examination of mass
66 44.0 44.9
81 54.0 55.1
147 98.0 100.0
3 2.0
150 100.0
Mass felt
Mass not felt
Total
Valid
SystemMissing
Total
Frequency Percent Valid Percent
Warmth
51 34.0 34.9
95 63.3 65.1
146 97.3 100.0
4 2.7
150 100.0
Present
Absent
Total
Valid
SystemMissing
Total
Frequency Percent Valid Percent
Tenderness
18 12.0 12.2
129 86.0 87.8
147 98.0 100.0
3 2.0
150 100.0
Present
Absent
Total
Valid
SystemMissing
Total
Frequency Percent Valid Percent
Pulsation
147 98.0 100.0
3 2.0
150 100.0
AbsentValid
SystemMissing
Total
Frequency Percent Valid Percent
Finger insinuation
45 30.0 30.6
102 68.0 69.4
147 98.0 100.0
3 2.0
150 100.0
Possible
Not Possible
Total
Valid
SystemMissing
Total
Frequency Percent Valid Percent
Resistance to retropulsion
94 62.7 63.9 63.9
53 35.3 36.1 100.0
147 98.0 100.0
3 2.0
150 100.0
Present
Absent
Total
Valid
SystemMissing
Total
Frequency Percent Valid Percent
Cumulative
Percent
Variation with posture
1 .7 .7
146 97.3 99.3
147 98.0 100.0
3 2.0
150 100.0
Present
Absent
Total
Valid
SystemMissing
Total
Frequency Percent Valid Percent
Mass was felt in 44% of cases and was not felt in 54% of cases .2% of cases could not be examined 
because of involvement of the eyeball by the tumor. Warmth was felt in 34% of cases and was not felt 
in 63.3% of cases .2.7% of cases could not be examined. Tenderness was present in 12% of cases while 
it was absent in 86% of cases .2% of cases could not be examined because of involvement by the 
tumor. Pulsation was absent in all the cases that could be examined (98%).Finger insinuation was 
possible in 30% of cases and was not possible in 68% of cases. Resistance to retropulsion was present 
in 62.7% of cases and was absent in 35.3% cases. Variation with posture was present in only.7% of 
cases and was absent in 97.3% of cases. Variation with valsalva manouevre was absent in all the cases 
that were examined. Bruit was absent in all the cases examined. Ocular movements were restricted in 
58% of cases and were normal in 40% of cases .2% of cases could not be examined because of 
involvement of the eyeball by the tumor.
Valsalva maneuver
147 98.0 100.0
3 2.0
150 100.0
AbsentValid
SystemMissing
Total
Frequency Percent Valid Percent
Bruit over the mass
147 98.0 100.0
3 2.0
150 100.0
AbsentValid
SystemMissing
Total
Frequency Percent Valid Percent
Ocular movements
60 40.0 40.8
87 58.0 59.2
147 98.0 100.0
3 2.0
150 100.0
Full
Restricted
Total
Valid
SystemMissing
Total
Frequency Percent Valid Percent
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Haematological
2 1.3 1.3
148 98.7 98.7
150 100.0 100.0
Done
Not Done
Total
Valid
Frequency Percent Valid Percent
X-Ray
147 98.0 98.0
2 1.3 1.3
1 .7 .7
150 100.0 100.0
Not Done
PNS
ORBIT
Total
Valid
Frequency Percent Valid Percent
USG B Scan
21 14.0 14.0
129 86.0 86.0
150 100.0 100.0
Done
Not Done
Total
Valid
Frequency Percent Valid Percent
CT Scan
117 78.0 78.0
33 22.0 22.0
150 100.0 100.0
Done
Not Done
Total
Valid
Frequency Percent Valid Percent
Histopathology
132 88.0 88.0
18 12.0 12.0
150 100.0 100.0
Done
Not Done
Total
Valid
Frequency Percent Valid Percent
Hematological investigation and X-ray PNS was done in 1.3% and X-ray orbits in .7%of cases, USG 
Scan in 14% of cases, CT scan in 78% of cases and histopathological examination was done in 88% of 
cases.
CT Scan
117 78.0 78.0
33 22.0 22.0
150 100.0 100.0
Done
Not Done
Total
Valid
Frequency Percent Valid Percent
Histopathology
132 88.0 88.0
18 12.0 12.0
150 100.0 100.0
Done
Not Done
Total
Valid
Frequency Percent Valid Percent
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MANAGEMENT
FREQUENCY PERCENTAGE
MEDICAL 10 6.7
SURGERY 73 48.7
CHEMOTHERAPY 9 6.0
RADIOTHERAPY 11 7.3
SX +CT 10 6.7
SX+RT 32 21.3
REF 4 2.7
TOTAL 149 99.3
ABSCONDED 1 .7
TOTAL 150 100
Sxsurgery; CTchemotherapy; RT radiotherapy;REFreferred for further management 
Medical therapy was instituted in 6.7% of cases. Surgery was done in 48.7% of cases, 
chemotherapy in 6%, radiotherapy in 7.3%, surgery and hemotherapy in 6.7%, surgery 
and radiotherapy in 21.3% of cases and 2.7% of the patients were referred. 1 patient 
absconded.
TUMOR TYPE 
PRIMARY , 82
SECONDARY, 
14.7
METASTASIS, 
3.3
PRIMARY 
SECONDARY
METASTASIS
BENIGN OR MALIGNANT
BENIGN 
51%
MALIGNANT
49%
DIAGNOSIS
Primary tumors constituted 82% of the cases, secondary 22% and metastasis constituted 3.3% of cases.
BENIGN OR  MALIGNANT
76 50.7
74 49.3
150 100.0
Benign
Malignant
Total
Frequency Percent
50.7% of the cases were benign tumors and 49.3% of cases were malignant tumors
Tumor Type
123 82.0
22 14.7
5 3.3
150 100.0
PRIMARY
SECONDARY
METASTASIS
Total
Frequency Percent
FREQUENCY OF PRIMARY TUMORS
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Primary tumors included–epithelial -19.5%, fibrous -6.5%, fibrosseus-4.8%,  cartilaginous - .8%, 
adipose-1.6%, vascular 23.5%, lymphoid and leukemic-15.4%, langerhans cell type -1.6%, neural 
-22.7% and striated muscle-3.5%.    
TUMOR CLASS
24 19.5
8 6.5
6 4.8
1 .8
2 1.6
29 23.5
19 15.4
2 1.6
28 22.7
4 3.5
123 100.0
Epithelial
Fibrous
Fibroosseus
Cartilage
Adipose
Vascular
Lymphoid/Leukemic
Langerhan's
Neural
Striated muscle
Total
Frequency Percent
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FIBROUS TUMORS
EPITHELIAL
FREQUENCY PERCENTAGE
PLEOMORPHIC ADENOMA 8 33.3
ADENOCARCINOMA
ADENOIDCYSTICCARCINOMA
CA FROM PLEOMORPHIC
CONJUNCTIVAL CYST
SQUAMOUS PAPPILOMA
3
10
1
1
1
12.5
41.6
4.2
4.2
4.2
Pleomorphic adenoma constituted 33.3% of the epithelial tumors,adenocarcinoma12.5%, adenoid 
cystic carcinoma 41.6%,and carcinoma from pleomorphic adenoma conjunctival cyst and squamous 
pappiloma being 4.2% each.
FIBROUS
FREQUENCY PERCENTAGE
FIBROUS HISTIOCYTOMA
FIBROMA
FIBROMATOSIS
FIBROSARCOMA
TOTAL
2
1
4
1
8
25
12.5
50
12.5
100
Fibromatosis (50%) was the most common tumor of the fibrous variety followed by fibrous 
histiocytoma (25%) and fibroma and fibrosarcoma being 12.5% each. 
Ossifying fibroma was 66.7%of the osteoid tumors while osteoid osteoma and pagets disease with 
osteosarcoma was16.7% each.
Lipoma constituted 100% of the adipose tissue tumors.
FIBROOSSEOUS
4 66.7
1 16.7
1 16.7
6 100.0
OSSIFYING FIBROMA
OSTEOID OSTEOMA
PAGETS DISEASE 
Total
Frequency Percent
. 
ADIPOSE
2 100.0LIPOMA
Frequency Percent
 
Chondrosarcoma was the only tumor of the cartilaginous variety encountered.
VASCULAR TUMORS
20.7
62.1
6.9
3.4
3.4
3.4
CAPILLARY
CAVERNOUS
HEE
HEP
KS
L
CARTILAGE
1 100.0CHONDROSARCOMA
Frequency Percent
 
LEUKEMIC /LYMPHOID TUMORS
ALL
AML
NHL 
PLAS
ALL
AML
NHL 
PLAS
Cappillary hemangioma constituted 20.7% , cavernous hemangioma 62.1%, 
hemangioendothelioma6.9%, hemangiopericytoma ,kaposis sarcoma and lymphangioma having3.4% 
eachof vascular tumors
LYMPHOID /LEUKEMIC
FREQUENCY PERCENTAGE
VASCULAR
6 20.7
18 62.1
2 6.9
1 3.4
1 3.4
1 3.4
29 100.0
CAPILLARY
HEMANGIOMACAVERNOUS
HEMANGIOMAE A I ENDO
OMAHEMANGIOPERICYTOMA
KAPOSI'S SARCOMA
LYMPHANGIOMA
Total
Frequency Percent
. 
ALL
AML
NHL
PLASMOCYTOMA
TOTAL
1
3
14
1
19
5.3
15.8
73.7
5.3
100
Non Hodgkins lymphoma was the most common leukemic/lymphoid tumor followed by acute myeloid 
leukemia. Acute lymphoid leukemia and plasmocytoma constituted 5.3% of the cases.
Eosinophilic granuloma was the only tumor encountered in the Langerhans cell variety.
FREQUENCY PERCENTAGE
GRANULAR CELL 
MYOBLASTOMA
RHABDOMYOSARCOMA
TOTAL
                     
                1
               3  
              4 
            25
             75
             100
                                           
Granular cell myoblastoma 25% and rhabdomyosarcoma  75% were the  tumors of the striated muscle 
variety
LANGERHANS
2 100.0
2 100.0
EOSINOPHILIC
GRANULOMA
Total
Frequency Percent
0 10 20 30 40
PERCENTAGE
GLIOMA
MENING
NEUROFI
SCHWAN
PO NEURO
TY
P
E
NEURAL TUMORS
SECONDARIES
36.6
13.54.518.1
13.6
4.5
9.1 SINUS 
RETINO
BCC
MGC
SCC
MELAN
ESTHESIO
NEURAL
FREQUENCY PERCENTAGE
OPTIC NERVE GLIOMA
MENINGIOMA
5
6
17.9
21.4
SCHWANNOMA
NEUROFIBROMA
PRIMARYORBITALNEUROEPITHI
TOTAL
6
10
1
28
21.4
35.7
3.6
100
Neurofibroma was the most common tumor of the neural variety 35.7%,meningioma and schwannoma 
being 21.4% each ,glioma 17.9%and primary orbital neuroepithelioma was 3.6%.
SECONDARIES
FREQUENCY PERCENTAGE
SINUS MALIGNANCY
BASAL CELL CARCINOMA
MALIGNANT MELANOMA
MEIBOMIAN GLAND  CA
ESTHESIONEUROBLASTOMA
RETINOBLASTOMA
SQUAMOUS CELL CA
TOTAL
8
1
1
4
2
3
3
22
36.6
4.5
4.5
18.1
9.1
13.6
13.6
100
Secondaries were common from the sinuses 36.6%,meibomian gland carcinoma 18.1% ,13.6% each 
retinoblastoma and squamous cell carcinoma esthesioneuroblastoma9.1% and basal cell carcinoma and 
malignant melanoma 4.5% each.
METASTASIS
FREQUENCY PERCENTAGE
PRIMARY UNKNOWN
BREAST
CLEAR CELL CA
CERVIX 
TOTAL
2
1
1
1
5
40
20
20
20
100
Metastasis were from breast, cervix and clear cell were encountered but majority of the primary was 
unknown 
DISCUSSION
A spectrum of tumors can involve the orbit .Several publications have addressed the 
incidence of space occupying lesions in the orbit. However the reported incidence of 
orbital  lesions show great  variation .Most  reported series of the frequency of orbital 
tumors are biased by various factors like specialty of the reviewer, histopathological 
confirmed lesions, age range of patients and geographic area of the patients. The present 
study differs from the other studies in that it includes patients seen in a tertiary care 
centre  and also  on  clinical  and pathologically  proven cases  and so  reflects  the  true 
incidence of orbital tumors seen in ophthalmic practices
Our study is compared to the five major studies done by Shield, Kennedy, Rootman, 
Henderson  and  Wilson.  Robert  Kennedy’s  series  was  based  on  the  tumor  registry, 
Shields  on the pathology specimens,  Henderson summarized  his  clinical  experience, 
Rootman  tabulated  his  orbital  practice  and  Wilson  summarized  the  orbital  lesions 
submitted to them. This study includes tumors encountered in a tertiary eye care centre 
and includes both the clinically and the pathologically proven cases.  
 Kennedy  collected  his  cases  in  a  time  period  of  34  years,  Shields  in  20  years, 
Henderson in 34 years, Rootman in 10 years and Wilson in 51 years while in this study 
the cases have been collected in a time frame of 18 months.
Type shields kennedy hender rootman wilson Our 
study
primary 188 284 662 244 76 123
(69%) (78.5%) (63.5%) (74.8%) (42%) (82%)
secondary 70
(26%)
51
(14%)
269
(25.8%)
44
(13.5%)
90
(50%)
22
(14.7%)
metastatic 16
(5%)
27
(7.5%)
111
(10.7%)
38
(11.7%)
15
(8%)
5
(3.3%)
    
 This table shows the distribution of tumors in the six studies compared with each 
other .Our study shows that the primary tumors were more in number compared to the 
other studies while secondaries were of same value and metastasis were  comparatively 
less in number
DISTRIBUTION OF PRIMARY TUMORS
Type Shield Kennedy Hender Rootm Wilson Study
Epith 11.1 6.3 10.2 6.1 6.57 19.5
Fibrous 5.85 0.7 3.02 5.3 2.63 6.5
Fibrooseus 4.25 9.85 4.68 8.6 3.9 4.8
Cartilage 1.06 0.35 1.05 0.8 _ 0.8
Adipose 1.06 _ 1.05 _ 3.9 1.6
Vascular 20.2 17.9 18.8 22.9 21 23.5
Neural 12.2 23.5 33.9 29 21 22.7
Striated 
Muscle
4.25 2.8 5.7 2.04 15.7 3.5
Lymph/Leu
k
38.8 37.6 19.3 22.5 21 15.4
Langerhans 0.53 1.05 1.66 1.6 3.9 1.6
Others 1.06 _ 0.6 0.8 _ _
Compared to the other studies, more malignant epithelial tumors than pleomorphic 
adenoma were noted and this may be due to the fact that ours is a tertiary care centre and 
the malignant lacrimal gland tumors were  referred for further management.
In the other studies, fibrous histiocytoma and fibrosarcoma were the most common 
while fibromatosis was the most  common lesion in oour study. All the lesions were 
confirmed by histopathology.
Ossifying fibroma was the most common tumor in the fibrosseous group which was 
unlike  that  of  the  other  studies  in  which  osteoma  and  fibrous  dysplasia  were  more 
common .Primary osteosarcoma of orbital bones were rare.
Primary neoplasms in cartilage and adipose tissue were infrequent in all the studies.
Vascular  tumors  showed  capillary  and  cavernous  hemangioma  to  be  the  most 
common tumors .Shields study was based on pathology specimens and so may have 
underestimated the frequency of these lesions and so may have some basis against these 
tumors .Our study, as being one including both histological  and clinically diagnosed 
lesions eliminates this basis and hence shows a higher number of vascular tumors.
Optic nerve glioma, neurofibroma and meningioma were the most common tumors 
of neural origin in all the six studies.
Lymphoid  and  leukemic  tumors  were  relatively  common  .The  most  common 
lymphoid tumor was Non Hodgkins Lymphoma except in the study done by Shields 
where lymphoid hyperplasia was more common.
All the tumors of the myogenic variety were malignant in all the six studies. 
The  three  most  common  primary  tumors  in  all  the  studies  put  together  were 
malignant lymphoma, cavernous hemangioma and meningioma while in our study it was 
malignant  lymphoma,  cavernous  hemangioma,  neurofibroma  and  adenoid  cystic 
carcinoma.  All  the  studies  show that  the  vascular,  neural  and the  lymphoid  type  of 
tumors were the most common tumor type. In my study epithelial tumors were found to 
be more common than in the other studies. 
In the secondary neoplasm’s invading the orbit the uveal melanoma was found to be 
the most common ocular tumor invading the orbit while in our study retinoblastoma was 
the more common one .This may be due to the fact that the uveal melanoma is more 
common in blue /grey iris than in brown iris. Squamous cell carcinoma was the most 
common adnexal tumor involving the orbit in the other studies while in our study it was 
meibomian gland carcinoma. Sinus tumors were also encountered in our study. Other 
rare tumors like esthesioneuroblastoma were also reported in our study.
In keeping with touch with the prior studies the most frequent metastatic neoplasms 
have been from the breast .In our study, we had 2 out of the 5 metastatic lesions, in 
which the primary was unknown
 All the studies had different inclusion criteria and the time interval for the six studies 
were different, which are considered to be the limitations of the study  
  
CONCLUSION
The age wise distribution in the study showed that the most common age group was the 
40-59 year age group with the mean age being 39.6 years 
In this study females were more commonly involved than males
In this study the most common state from where the patients presented was Tamil nadu and 
the second being from Kerala
In this study the left eye was more commonly involved than the right eye
The most common presenting symptom was proptosis followed by the presence of a mass.
All patients who had the disease before had taken treatment for it before. Family history was 
positive only in 2% of cases.
The visual acuity was between 6/6 -6/18 in most of the patients
The eye lids and the conjunctiva were normal in most of the cases. The most common 
presentation in the eyelids were ptosis and the chemosis and congestion and chemosis were 
present in all the other cases .Pupil reaction was normal in most of the cases and the fundus 
was normal in most of the cases examined. 
Unilateral presentation was more common than bilateral and eccentric proptosis was more 
common than axial proptosis
Mass felt, warmth ,tenderness ,resistance to retropulsion ,pulsation ,variation with posture 
and valsalva manouvre and bruit were not felt in most of the cases .Ocular movements were 
restricted in most of the cases.
Histopathological examination and CT scan were the two most common investigations done
Surgery was the most common modality of treatment followed by a combination of surgery 
and radiotherapy.
Benign tumors were more common than the malignant ones.
Vascular, neural and epithelial tumors were the most common tumors encountered.
The most common primary tumors were malignant lymphoma ,cavernous hemangioma 
,neurofibroma and adenoid cystic carcinoma.
ANNEXURE
PROFORMA
   NAME     AGE SEX
    MRNO         STATE             TAMIL NADU—1
   KERALA—2
   ANDHARAPRADESH—3
KARNATAKA—4
OTHERS—5
PRESENTING COMPLAINTS
AFFECTED EYE            RE1     LE 2        BE3
SYMPTOMS          PRESENT—> 1
                                   ABSENT—>   2
                                   IF PRESENT DURATION
DEFECTIVE VISION
DOUBLE VISION
DROOPING OF EYELIDS
PROTRUSION OF EYEBALL
PAIN
MASS
PAST HISTORY                                    YES 1    NO 2
IF YES TREATED OR NOT
FAMILY HISTORY                              YES1   NO2
OCULAR EXAMINATION
VISUAL ACUITY                RE                            LE
EYELIDS                         1 NORMAL   2 PTOSIS    3LAGOPTHALMOS 
4OTHERS   
CONJUNCTIVA               1NORMAL     2CONGESTED  3CHEMOSIS
PUPIL REACTION          1 PRESENT     2ABSENT     3RAPD
FUNDUS                            1NORMAL      2ABNORMAL
LATERALITY                    1U/L            2B/L
TYPE OF PROPTOSIS  1AXIAL 2ECCENTRIC
IF PROPTOSIS IS AXIAL
HERTLES EXOPHTHALMOMETRY OD OS   BASE
MASS PRESENT1 ABSENT2
WARMTH PRESENT1 ABSENT2
TENDERNESS PRESENT1 ABSENT2
PULSATIONS PRESENT1 ABSENT2
COMPRESSIBILITY PRESENT1 ABSENT2
FINGER INSINUATION POSSIBLE1 NOT POSSIBLE2
RESISTANCE TO RETROPULSION PRESENT1 ABSENT2
VARIATIONS WITH POSTURE PRESENT1 ABSENT2
VALSALVA MANOUVRE PRESENT1 ABSENT2
BRUIT OVER THE MASS PRESENT1 ABSENT2
OCULAR MOVEMENTS FULL1  RESTRICTED2
INVESTIGATIONS
HEMATOLOGICAL 1 DONE 2NOT DONE
X-RAY                     1NOT DONE 2PNS 3ORBIT
                                                   4OPTIC FORAMEN 5SKULL
CT SCAN 1DONE 2NOT DONE
USG 1DONE 2NOT DONE
HISTOPATHOLOGY 1DONE 2NOT DONE
OTHERS 1DONE 2NOT DONE
MANAGEMENT
1 MEDICAL
2 SURGERY
3 CHEMOTHERAPY
4 RADIOTHERAPY
5 SURGERY AND CHEMOTHERAPY
6 SURGERY AND RADIOTHERAPY
7 REFFERED FOR FURTHER MANAGEMENT
DIAGNOSIS
TYPE OF TUMOR 1PRIMARY 2SECONDARY           3METASTASIS
CLASS OF TUMOR 1-EPITHELIAL 2-FIBROUS   3-FIBROOSSEUS
4-CARTILAGE 5-ADIPOSE 6-VASCULAR
7-LYMPHOID/LEUKEMIC 8-LANGERHANSCELL 
9-NEURAL 10-STRIATED MUSCLE
11-SECONDARY 12-METASTATIC
NATURE OF TUMOR 1BENIGN 2MALIGNANT
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